Wong et al [20] simulated life histories using Markov health states to assess the effect of the implementation of echocardiographic screening followed by angiotensin-converting enzyme inhibitor and β-blocker therapy in survivors of childhood cancer on cost-effectiveness, life expectancy, QALYs, and the cumulative incidence of heart failure 30 years after a cancer diagnosis. The gene discussed is ACE; the disease is heart failure.